Clinical Trial Update: Radical Resection With Contralateral Lymph Node Dissection for Clinical N3 NSCLC [NA]

View source ↗

Summary

A surgical trial evaluating radical resection with contralateral lymph node dissection for clinical N3 non-small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: NSCLC, Non Small Cell Lung Cancer | NA | Status: RECRUITING